Observations on the systemic effect of topical clobetasol propionate (Dermovate).

Authors:
  • JCJ A Carruthers
    J A Carruthers
  • PAP J August
    P J August
  • RSR C Staughton
    R C Staughton

Abstract
Topical application of clobetasol propionate in a strength of 0-05% in cream or ointment (Dermovate) suppressed the hypothalamic-pituitary-adrenal axis in both normal people and patients with diseased skin. In normal people the 9 am serum cortisol level was suppressed when between 45 and 90 g was applied weekly. Insulin stress test results in patients with diseased skin showed an abnormally small response after long-term application of similar amounts. We conclude that long-term administration should be restricted to less than 50 g a week.

This publication has 8 references indexed in Scilit: